Stockscreener 앱 받기
0.8334
55.43%
-1.0366
시간 외 거래:
.83
-0.0034
-0.41%
Reviva Pharmaceuticals Holdings Inc 주식(RVPH)의 최신 뉴스
Reviva Pharmaceuticals Announces $10 Million Equity Offering - TipRanks
Reviva Pharmaceuticals (NASDAQ: RVPH) raises equity with detachable warrants and pre‑funded options - Stock Titan
Reviva (NASDAQ: RVPH) prices $10M equity deal to fund Phase 3 trial - Stock Titan
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
What's Behind The Drop In Reviva Pharmaceuticals Stock? - Benzinga
Dow Falls Over 300 Points; US Initial Jobless Claims Fall - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
$10M raise backs Reviva's Phase 3 schizophrenia drug trial - Stock Titan
Reviva Pharmaceuticals prices $10M public offering at $1.50 By Investing.com - Investing.com India
Reviva Pharmaceuticals announces public stock and warrant offering By Investing.com - Investing.com South Africa
Why Did RVPH Stock Crash 40% In Pre-Market Today? - Stocktwits
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - GlobeNewswire
Reviva Pharmaceuticals announces pricing of $10 million public offering at $1.50 per share - marketscreener.com
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering - Benzinga
Reviva Pharmaceuticals announces public stock and warrant offering - Investing.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Reviva Pharmaceuticals (NASDAQ: RVPH) proposes sale of stock, warrants to fund Phase 3 - Stock Titan
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - GlobeNewswire
Reviva seeks fresh cash for Phase 3 schizophrenia trial - Stock Titan
Gainers Report: Is now the right time to enter Reviva Pharmaceuticals Holdings IncQuarterly Trade Review & Growth-Oriented Investment Plans - baoquankhu1.vn
Setup Watch: Should I hold or sell Conduit Pharmaceuticals Inc now2026 Retail Activity & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
symbol__ Stock Quote Price and Forecast - CNN
Value Recap: What makes Reviva Pharmaceuticals Holdings Inc stock attractive todayGDP Growth & AI Based Trade Execution Alerts - baoquankhu1.vn
Breakout Watch: How correlated is Reviva Pharmaceuticals Holdings Inc to the S P5002026 Rallies & AI Enhanced Execution Alerts - baoquankhu1.vn
Volume Summary: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investmentInflation Watch & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 - Investing.com Nigeria
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold By Investing.com - Investing.com Nigeria
Reviva Pharmaceuticals Holdings Inc NPV Share Price - Hargreaves Lansdown
Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears - TechStock²
HC Wainwright & Co. Maintains Reviva Pharmaceuticals Holdings (RVPH) Buy Recommendation - MSN
US Market Wrap: Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant announce a stock splitPortfolio Value Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Reviva Pharmaceuticals Announces Major Share Consolidation Plan - AD HOC NEWS
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock reacts to inflationary pressures2025 Pullback Review & Weekly High Potential Stock Alerts - Naître et grandir
CEO Moves: Is now the right time to enter Reviva Pharmaceuticals Holdings Inc2025 Market WrapUp & Risk Controlled Swing Alerts - baoquankhu1.vn
Reviva Pharmaceuticals (RVPH) Downgraded to Hold by D. Boral Cap - GuruFocus
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold - Investing.com
Reviva Pharmaceuticals Announces One-for-Twenty Reverse Stock Split - TipRanks
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9 By Investing.com - Investing.com India
D Boral Capital downgrades Reviva Pharmaceuticals Holdings (RVPH) - MSN
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
RVPH PE Ratio & Valuation, Is RVPH Overvalued - Intellectia AI
Risks Report: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channel2025 Price Momentum & Real-Time Volume Analysis - baoquankhu1.vn
Rate Hike: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant stock outperform in a bear marketShort Setup & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Levels Update: Will Reviva Pharmaceuticals Holdings Inc benefit from sector rotationJuly 2025 WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Sentiment: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflation2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn
Trade Report: Is Reviva Pharmaceuticals Holdings Inc exposed to currency risks2025 Price Momentum & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Guidance Update: Is Reviva Pharmaceuticals Holdings Inc forming a bullish divergenceJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
Earnings Beat: Does Flywire Corporation stock have upside surprise potentialJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and Prenetics Group (PRE) - The Globe and Mail
What technical signals suggest for Reviva Pharmaceuticals Holdings Inc. stockJuly 2025 Market Mood & Real-Time Market Trend Scan - mfd.ru
Loss Report: Is ProShares Trust ProShares UltraPro MidCap400 stock forming a cup and handle2025 Volume Leaders & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Market Pulse: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant a good ESG investment2025 Top Gainers & Weekly High Return Forecasts - baoquankhu1.vn
Aug Spikes: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant in a bullish channelJuly 2025 Final Week & Weekly Breakout Watchlists - baoquankhu1.vn
Schizophrenia Market: Expanding Revenue Landscape to 2034 - openPR.com
Schizophrenia Market: Expanding Revenue Landscape to 2034 – DelveInsight | Teva Pharma, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharma, Reviva Pharma, Minerva Neurosciences - Barchart.com
Insider Sell: Is AMHPRG part of any ETF2025 Year in Review & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform in a bear marketShort Setup & Smart Investment Allocation Tips - mfd.ru
Can Reviva Pharmaceuticals Holdings Inc. stock surprise with earnings upsideQuarterly Trade Summary & Free Risk Controlled Daily Trade Plans - mfd.ru
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock outperform tech sector in 2025Weekly Profit Report & Safe Entry Momentum Stock Tips - mfd.ru
Why is Reviva Pharmaceuticals Holdings Inc. stock going down2025 Market Trends & Low Risk Entry Point Guides - mfd.ru
How Reviva Pharmaceuticals Holdings Inc. stock compares to industry benchmarksJuly 2025 Decliners & High Accuracy Swing Entry Alerts - mfd.ru
What’s Reviva Pharmaceuticals Holdings Inc.’s historical returnWeekly Profit Summary & Growth Focused Stock Pick Reports - mfd.ru
Growth Value: Will Quetta Acquisition Corporation Equity Right outperform its industry peersFed Meeting & Fast Entry and Exit Trade Plans - baoquankhu1.vn
1.20%
0.06%
자본화:
|
볼륨(24시간):